Janus Living
JAN
27.83
-0.73
-2.56%
Janus Living
US · JAN
#1620 by market cap
Listed 2026
27.83
-0.73
-2.56%
Live - 5344 symbols - heartbeat 187s ago
· 2026-10-07 19:54
After-hours
27.83
0.00%
- Market cap
- 6.52B
- P/E (TTM)i
- 456.23
- P/Bi
- 2.38
- EPSi
- -0.34
- Div yieldi
- 0.74%
- 52W posi
- 52%
Reader sentiment
Are you bullish or bearish on JAN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.00, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +35.66% YoY
Margins
- Operating margin
- -12.17%
- Net margin
- -7.92%
Key ratios & quality
- Altman Z-Scorei
- 4.00
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 36.79M | 35.10M | 33.87M | 40.02M | 0 | 0 | 568.48M | 771.17M |
| Gross profit | 11.05M | 7.79M | 8.83M | 8.87M | 0 | 0 | -- | -- |
| Selling & admin expenses | 17.15M | 20.22M | 17.82M | 12.09M | 3.15M | 4.75M | 11.92M | 14.72M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -6.10M | -12.43M | -9.00M | -3.22M | -3.15M | -4.75M | -11.08M | -93.88M |
| Pretax profit | -6.34M | -15.16M | -8.93M | -3.04M | 1.40M | -17.52M | -63.85M | -68.69M |
| Tax | -727.00K | -3.20M | -427.00K | 273.00K | -6.62M | -429.00K | -11.49M | 18.10M |
| Net profit | -5.61M | -11.96M | -8.50M | -16.89M | 10.99M | -7.81M | -50.46M | -86.79M |
| Basic EPS | -4 | -7 | -5 | -6 | 3 | -2 | 0 | 0 |
| Diluted EPS | -3.75 | -6.78 | -4.59 | -6.35 | 3.49 | -1.95 | -0.28 | -0.34 |
| Line item | 2023-12 | 2024-03 | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 148.93M | 148.86M | 200.35M | 216.46M |
| Gross profit | 0 | 0 | -- | -- | -- | -- |
| Selling & admin expenses | 1.82M | 1.81M | 3.13M | 2.38M | 3.29M | 3.81M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -1.82M | -1.81M | 2.36M | 3.50M | 1.06M | -2.61M |
| Pretax profit | -16.43M | -2.22M | -970.00K | -1.48M | 28.89M | 13.11M |
| Tax | -160.00K | -75.00K | 2.59M | 2.10M | 1.12M | -1.75M |
| Net profit | -17.81M | -2.14M | -2.11M | -2.57M | 27.87M | 14.86M |
| Basic EPS | -5 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | -4.66 | -0.34 | -0.01 | -0.01 | -0.05 | 0.05 |
Balance sheet
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 8.94M | 8.84M | 6.94M | 7.56M | 9.17M | 346.00K | 179.87M | 916.02M |
| Cash & ST investments | 1.20M | 481.00K | 379.00K | 705.00K | 61.00K | 5.00K | 18.78M | 828.09M |
| Inventory | 801.00K | 1.35M | 1.63M | 1.10M | -- | -- | -- | -- |
| Total assets | 35.04M | 29.03M | 24.35M | 15.17M | 46.76M | 18.49M | 2.34B | 3.52B |
| Total current liabilities | 9.68M | 17.57M | 20.60M | 19.37M | 23.94M | 5.91M | 928.20M | 1.01B |
| Short-term debt | 675.00K | 3.83M | 5.24M | 2.85M | 274.00K | -- | -- | -- |
| Long-term debt | -- | -- | -- | 1.32M | -- | 707.00K | 106.25M | -- |
| Total liabilities | 13,429,000.00 | 18,693,000.00 | 21,985,000.00 | 23,841,000.00 | 44,449,000.00 | 21,795,000.00 | 1,034,449,000.00 | 1,007,880,000.00 |
| Total equity | 21.61M | 10.34M | 2.37M | -8.68M | 2.31M | -3.31M | 1.31B | 2.51B |
| Retained earnings | -16.52M | -28.42M | -36.92M | -53.80M | -42.82M | -50.63M | -- | 43.94M |
| Line item | 2023-12 | 2024-03 | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 346.00K | 1.19M | -- | -- | 1.14B | 1.74B |
| Cash & ST investments | 5.00K | 61.00K | -- | -- | 948.82M | 1.56B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 18.49M | 18.58M | -- | -- | 4.02B | 4.71B |
| Total current liabilities | 5.91M | 8.08M | -- | -- | 977.86M | 1.01B |
| Short-term debt | -- | 600.00K | -- | -- | -- | -- |
| Long-term debt | 707.00K | 2.31M | -- | -- | -- | -- |
| Total liabilities | 21,795,000.00 | 14,805,000.00 | -- | -- | 977,857,000.00 | 1,005,391,000.00 |
| Total equity | -3.31M | 3.77M | -- | -- | 3.05B | 3.70B |
| Retained earnings | -50.63M | -52.78M | -- | -- | -8.56M | -31.77M |
Cash flow
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.15M | -3.51M | -617.00K | -5.29M | -3.06M | 1.46M | 128.56M | 136.82M |
| Depreciation & amortization | 4.00M | 4.08M | 4.12M | 4.17M | 2.00K | 1.45M | 137.19M | 126.36M |
| Free cash flow | 3.74M | -4.01M | -1.45M | -7.02M | -3.06M | 1.46M | 63.50M | 12.90M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -79.64M | -32.89M |
| Stock buybacks / issuance | -- | -- | 0 | 5.54M | 0 | 792.00K | -- | -- |
| Ending cash balance | 1.20M | 481.00K | 379.00K | 705.00K | 61.00K | 5.00K | 79.07M | 84.26M |
| Line item | 2023-12 | 2024-03 | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -409.00K | -544.00K | 20.82M | 49.48M | 33.32M | 79.57M |
| Depreciation & amortization | 362.00K | 639.00K | 32.80M | 31.19M | 51.40M | 56.47M |
| Free cash flow | -409.00K | -544.00K | 5.22M | 11.23M | 13.31M | 53.70M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 600.00K | 0 | 0 | 902.09M | 691.20M |
| Ending cash balance | 5.00K | 61.00K | 84.63M | 88.99M | 1.04B | 1.65B |
Returns & efficiency
| Line item | 2018 | 2019 | 2021 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -23.44 | -74.89 | -133.75 | -- | 270.04 | -115.66 | -3.86 | -3.97 |
| ROA %i | -13.76 | -37.59 | -31.84 | -85.47 | 35.50 | -23.95 | -2.15 | -2.08 |
| ROIC %i | -20.78 | -63.40 | -70.77 | -- | 83.56 | -100.19 | -3.34 | -3.89 |
| 5-year avg ROE %i | -10.37 | -26.52 | -48.91 | -- | -- | -- | -- | -- |
| EBIT margin %i | -16.57 | -35.42 | -26.56 | -39.58 | -6.55 | -- | -10.54 | -8.70 |
| FCF / sales %i | 10.18 | -- | -- | -- | -- | -- | 11.17 | 1.67 |
| Current ratioi | 0.92 | 0.50 | 0.34 | 0.39 | 0.38 | 0.06 | 0.19 | 0.91 |
| Quick ratioi | 0.73 | 0.41 | 0.20 | 0.25 | 0.01 | 0.05 | 0.13 | 0.84 |
| Debt / assetsi | 1.93 | 16.13 | 27.21 | 43.79 | 0.59 | 3.82 | 4.53 | -- |
| LT debt / equityi | -- | 8.22 | 58.66 | -- | -- | -- | 8.12 | -- |
| Interest coveragei | -- | -- | -- | -20.49 | -5.30 | -- | -15.20 | -40.99 |
| Revenue CAGR (3Y) %i | -30.97 | -4.63 | -6.58 | 2.84 | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2023-12 | 2024-03 | 2025-03 | 2025-06 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -115.66 | -231.25 | -- | -- | -3.12 | -1.98 |
| ROA %i | -23.95 | -74.84 | -- | -- | -1.68 | -1.15 |
| ROIC %i | -100.19 | -177.18 | -- | -- | -3.09 | -1.97 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -- | -- | -- | -- | -4.59 | -2.67 |
| FCF / sales %i | -- | -- | -- | -- | 2.55 | 7.13 |
| Current ratioi | 0.06 | 0.15 | -- | -- | 1.17 | 1.73 |
| Quick ratioi | 0.05 | 0.05 | -- | -- | 1.08 | 1.65 |
| Debt / assetsi | 3.82 | 15.66 | -- | -- | -- | -- |
| LT debt / equityi | -- | 61.22 | -- | -- | -- | -- |
| Interest coveragei | -- | -- | -- | -- | -36.38 | -54.09 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Room and rents is the largest reported line at 78.15% of revenue, across 3 reported segments.
- The next-largest line, Non-refundable entrance fee amortization, is a distant second at 12.85% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Room and rents78.15%
Non-refundable entrance fee amortization12.85%
Ancillary and other services9.01%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.